Cargando…
Nilotinib-Induced Acute Pancreatitis in a Patient with Chronic Myeloid Leukemia
Nilotinib, a second-generation tyrosine kinase inhibitor, is used for treatment of chronic myeloid leukemia (CML); it has been widely used especially for imatinib-resistant CML. Despite being a novel drug in this therapeutic class, it has the potential to be harmful. We present the case of an elderl...
| Autores principales: | , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
S. Karger AG
2017
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5471777/ https://www.ncbi.nlm.nih.gov/pubmed/28626381 http://dx.doi.org/10.1159/000468510 |